Arcutis Biotherapeutics Inc (ARQT) Insider Trading
- $26,579,888.32
- $24,425,732.15
- Nov. 15, 2024
- Todd Franklin Watanabe
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Nov. 15, 2024 | Insider | 100 | $10.03 | Sell | $1,003.00 | |
Nov. 11, 2024 | Director | 8,687 | $10.85 | Sell | $94,253.95 | |
Nov. 4, 2024 | Insider | 5,015 | $8.68 | Sell | $43,530.20 | |
Nov. 1, 2024 | Director | 10,000 | $8.65 | Sell | $86,500.00 | |
Oct. 2, 2024 | SVP | 3,725 | $10.01 | Sell | $37,287.25 | |
Oct. 1, 2024 | Director | 10,000 | $9.26 | Sell | $92,600.00 | |
Sept. 24, 2024 | CFO | 11,626 | $9.48 | Sell | $110,214.48 | |
Sept. 3, 2024 | Director | 10,000 | $10.77 | Sell | $107,700.00 | |
Aug. 19, 2024 | Insider | 1,728 | $8.29 | Sell | $14,325.12 | |
Aug. 2, 2024 | Insider | 5,220 | $9.02 | Sell | $47,084.40 | |
Aug. 1, 2024 | Director | 10,000 | $9.87 | Sell | $98,700.00 | |
July 1, 2024 | Director | 10,000 | $9.31 | Sell | $93,100.00 | |
May 30, 2024 | Insider | 23,000 | $8.75 | Sell | $201,250.00 | |
May 28, 2024 | Insider | 1,775 | $9.01 | Sell | $15,992.75 | |
May 17, 2024 | SVP | 7,640 | $8.98 | Sell | $68,607.20 | |
March 4, 2024 | Insider | 3,760 | $11.12 | Sell | $41,811.20 | |
Jan. 2, 2024 | Insider | 1,325 | $3.54 | Sell | $4,690.50 | |
Nov. 21, 2023 | Insider | 1,850 | $1.98 | Sell | $3,663.00 | |
Oct. 24, 2023 | Major Shareholder | 80,000 | $2.50 | Buy | $200,000.00 | |
Aug. 21, 2023 | Insider | 1,605 | $7.04 | Sell | $11,299.20 | |
May 31, 2023 | Insider | 1,830 | $7.80 | Sell | $14,274.00 | |
April 17, 2023 | Director | 8,500 | $13.97 | Sell | $118,745.00 | |
April 6, 2023 | Director | 8,500 | $12.01 | Sell | $102,085.00 | |
March 6, 2023 | Insider | 2,435 | $15.26 | Sell | $37,158.10 | |
March 6, 2023 | CFO | 291 | $15.26 | Sell | $4,440.66 | |
March 6, 2023 | SVP | 831 | $15.26 | Sell | $12,681.06 | |
March 2, 2023 | Insider | 5,472 | $15.83 | Sell | $86,621.76 | |
March 2, 2023 | CFO | 1,434 | $15.83 | Sell | $22,700.22 | |
March 2, 2023 | SVP | 1,432 | $15.83 | Sell | $22,668.56 | |
Feb. 28, 2023 | Insider | 2,343 | $16.17 | Sell | $37,886.31 | |
Feb. 28, 2023 | CFO | 416 | $16.17 | Sell | $6,726.72 | |
Feb. 28, 2023 | SVP | 936 | $16.17 | Sell | $15,135.12 | |
Feb. 15, 2023 | Director | 8,500 | $16.98 | Sell | $144,330.00 | |
Feb. 13, 2023 | Insider | 483 | $17.00 | Sell | $8,211.00 | |
Jan. 17, 2023 | Director | 8,500 | $13.72 | Sell | $116,620.00 | |
Jan. 3, 2023 | Insider | 1,475 | $15.01 | Sell | $22,139.75 | |
Dec. 7, 2022 | Insider | 1,000 | $17.06 | Sell | $17,060.00 | |
Nov. 21, 2022 | Insider | 1,720 | $18.19 | Sell | $31,286.80 | |
Nov. 7, 2022 | Insider | 1,000 | $18.00 | Sell | $18,000.00 | |
Oct. 7, 2022 | CEO | 1,000 | $19.51 | Sell | $19,510.00 | |
Oct. 4, 2022 | Director | 6,000 | $20.29 | Sell | $121,740.00 | |
Sept. 7, 2022 | CEO | 1,000 | $21.51 | Sell | $21,510.00 | |
Aug. 15, 2022 | Director | 6,000 | $24.80 | Sell | $148,800.00 | |
July 18, 2022 | N/A | 6,000 | $24.40 | Sell | $146,400.00 | |
July 18, 2022 | Director | 6,000 | $24.40 | Sell | $146,400.00 | |
July 8, 2022 | President and CEO | 1,500 | $25.00 | Sell | $37,500.00 | |
July 8, 2022 | Chief Technical Officer | 2,197 | $25.41 | Sell | $55,825.77 | |
July 6, 2022 | CEO | 1,000 | $22.07 | Sell | $22,070.00 | |
June 24, 2022 | Major Shareholder | 341,971 | $21.31 | Sell | $7,287,402.01 | |
June 2, 2022 | SVP | 1,795 | $19.73 | Sell | $35,415.35 |
Insiders are both buying and selling Arcutis Biotherapeutics Inc stock.
The insider traders at Arcutis Biotherapeutics Inc are: Todd Franklin Watanabe, Howard G Welgus, Patrick Burnett, Masaru Matsuda, Bhaskar Chaudhuri, Scott L Burrows, John W. Smither, Patricia A Turney, Orbimed Advisors Llc, Life Sciences Viii L Frazier, Larry Todd Edwards, Howard G. Welgus, David W Osborne, Welgus Howard G., Terrie Curran, David Joseph Topper, Watanabe Todd Franklin, Jonathan Silverstein, David W. Osborne, and OSBORNE DAVID W
The most active insider trader at Arcutis Biotherapeutics Inc is Todd Franklin Watanabe with 28 trades.
Orbimed Advisors Llc has sold the most Arcutis Biotherapeutics Inc stock with a total value of $25,610,794.78.
Jonathan Silverstein has bought the most Arcutis Biotherapeutics Inc stock with a total value of $28,659,776.64.
The most recent insider trade for Arcutis Biotherapeutics Inc was on Nov. 15, 2024.
The single biggest insider buy for Arcutis Biotherapeutics Inc was from Jonathan Silverstein with a total value of $14,329,888.32 on Feb. 3, 2020.
The single biggest insider sell for Arcutis Biotherapeutics Inc was from Orbimed Advisors Llc with a total value of $7,287,402.01 on June 24, 2022.